IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 86 filers reported holding IMMUNIC INC in Q1 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,014 | -41.6% | 110,214 | -0.3% | 0.00% | – |
| Q2 2023 | $277,576 | +90.7% | 110,588 | +13.2% | 0.00% | – |
| Q1 2023 | $145,585 | +27.7% | 97,708 | +20.0% | 0.00% | – |
| Q4 2022 | $114,035 | -55.1% | 81,454 | +1.4% | 0.00% | – |
| Q3 2022 | $254,000 | -3.4% | 80,348 | +6.0% | 0.00% | – |
| Q2 2022 | $263,000 | -87.6% | 75,772 | -59.7% | 0.00% | – |
| Q1 2022 | $2,126,000 | +21.6% | 188,148 | +3.0% | 0.00% | – |
| Q4 2021 | $1,748,000 | +8.6% | 182,595 | +0.4% | 0.00% | – |
| Q3 2021 | $1,610,000 | -20.5% | 181,867 | +10.0% | 0.00% | – |
| Q2 2021 | $2,026,000 | +26.8% | 165,289 | +64.9% | 0.00% | – |
| Q1 2021 | $1,598,000 | -10.8% | 100,257 | -14.4% | 0.00% | – |
| Q4 2020 | $1,791,000 | -21.1% | 117,143 | -4.2% | 0.00% | – |
| Q3 2020 | $2,270,000 | +131.9% | 122,217 | +51.4% | 0.00% | – |
| Q2 2020 | $979,000 | – | 80,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
| Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
| INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
| Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
| RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
| Logos Global Management LP | 421,184 | $619,140 | 0.08% |
| Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
| BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
| Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
| COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |